These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21410287)

  • 21. Functional expression of mouse insulin-like growth factor-I with food-grade vector in Lactococcus lactis NZ9000.
    Gao G; Qiao JJ; Yang CH; Jiang DZ; Li RQ; Su JJ; Xu HJ; Zhang XM; Bai YL; Qiao MQ
    Lett Appl Microbiol; 2012 May; 54(5):404-9. PubMed ID: 22332956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introducing glutathione biosynthetic capability into Lactococcus lactis subsp. cremoris NZ9000 improves the oxidative-stress resistance of the host.
    Fu RY; Bongers RS; van Swam II; Chen J; Molenaar D; Kleerebezem M; Hugenholtz J; Li Y
    Metab Eng; 2006 Nov; 8(6):662-71. PubMed ID: 16962352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells.
    Zhang B; Li A; Zuo F; Yu R; Zeng Z; Ma H; Chen S
    Microb Cell Fact; 2016 Jun; 15(1):102. PubMed ID: 27287327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
    Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous expression of Lactobacillus casei RecO improved the multiple-stress tolerance and lactic acid production in Lactococcus lactis NZ9000 during salt stress.
    Wu C; Zhang J; Du G; Chen J
    Bioresour Technol; 2013 Sep; 143():238-41. PubMed ID: 23796607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice.
    Ren C; Zhang Q; Wang G; Ai C; Hu M; Liu X; Tian F; Zhao J; Chen Y; Wang M; Zhang H; Chen W
    Appl Microbiol Biotechnol; 2014; 98(14):6353-64. PubMed ID: 24770368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice.
    Chatel JM; Nouaille S; Adel-Patient K; Le Loir Y; Boe H; Gruss A; Wal JM; Langella P
    Appl Environ Microbiol; 2003 Nov; 69(11):6620-7. PubMed ID: 14602621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of EspA in Lactococcus lactis NZ9000 and the detection of its immune effect in vivo and vitro.
    Luan J; Zhuang Z; Liu Y; Yun K; Chen M; Wang PG
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):133-40. PubMed ID: 20001787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
    Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
    Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome sequences of Lactococcus lactis MG1363 (revised) and NZ9000 and comparative physiological studies.
    Linares DM; Kok J; Poolman B
    J Bacteriol; 2010 Nov; 192(21):5806-12. PubMed ID: 20639323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
    Medina M; Villena J; Salva S; Vintiñi E; Langella P; Alvarez S
    Microbiol Immunol; 2008 Aug; 52(8):399-409. PubMed ID: 18667039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved acid-stress tolerance of Lactococcus lactis NZ9000 and Escherichia coli BL21 by overexpression of the anti-acid component recT.
    Zhu Z; Ji X; Wu Z; Zhang J; Du G
    J Ind Microbiol Biotechnol; 2018 Dec; 45(12):1091-1101. PubMed ID: 30232653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologous expression of the Bacillus subtilis (natto) alanine dehydrogenase in Escherichia coli and Lactococcus lactis.
    Ye W; Huo G; Chen J; Liu F; Yin J; Yang L; Ma X
    Microbiol Res; 2010 May; 165(4):268-75. PubMed ID: 19720515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glutathione plays an anti-oxidant role in Lactococcus lactis].
    Fu RY; Chen J; Li Y
    Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):379-84. PubMed ID: 16933605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transposition of IS10R in Lactococcus lactis.
    Kjos M; Straume D; Nes IF; Diep DB
    J Appl Microbiol; 2009 Jan; 106(1):288-95. PubMed ID: 19120617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug delivery by genetically modified Lactococcus lactis.
    Steidler L; Rottiers P
    Ann N Y Acad Sci; 2006 Aug; 1072():176-86. PubMed ID: 17057198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of Polysaccharides-Capped Selenium Nanoparticles Using
    Xu C; Qiao L; Ma L; Yan S; Guo Y; Dou X; Zhang B; Roman A
    Front Microbiol; 2019; 10():1632. PubMed ID: 31402902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.